hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06378736, orgStudyIdInfo id: 21-1027, briefTitle: Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-22, primaryCompletionDateStruct date: 2026-03-23, completionDateStruct date: 2026-03-23, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-29, sponsorCollaboratorsModule leadSponsor name: Northwell Health, class: OTHER, descriptionModule briefSummary: Patients with systemic lupus erythematosus (SLE) often experience a frustrating decline of their cognitive skills that includes considerable problems in attention, learning, and memory. This lupus-related cognitive dysfunction (termed SLE-CD) is recognized as the most prevalent of the nineteen neuropsychiatric SLE syndromes, as it affects up to 80% of patients and can significantly decrease their quality of life. The goal is to have tools that can be used for diagnosis and for monitoring responses after targeted interventions and therapies. This study will focus on electroencephalographic (EEG) signals, which will be detected noninvasively from scalp placed surface electrodes while the subjects are in a state of wakeful rest. Our hypothesis is that a subset of brain oscillations known as theta and gamma, and their co-modulation or coupling will be disrupted in SLE patients. This research protocol will subject patients with systemic lupus erythematosus (SLE) to scalp electroencephalography (EEG), with the goal of determining whether specific EEG patterns ('theta-gamma coupling') appear abnormal during wakeful-rest periods of 20 minutes. The investigators are interested in using scalp EEG because it is a standard, safe and robust technique for monitoring the electrophysiological activity of neurons in the cerebral cortex., conditionsModule conditions: Systemic Lupus Erythematosus, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: PROSPECTIVE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Electroencephalography (EEG) signals, which will be detected noninvasively from dry scalp surface electrodes while the subjects are in a state of wakeful rest., outcomesModule primaryOutcomes measure: A measure of the amount and relationship of theta and gamma waves in the EEG recording. The ability to perform the block building task and the ability to choose among unfolded three-dimensional objects., eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Northwell Health-Feinstein Insitute, status: RECRUITING, city: Manhasset, state: New York, zip: 11030, country: United States, contacts name: Bruce T Volpe, MD, role: CONTACT, phone: 516-562-3384, email: bvolpe1@northwell.edu, contacts name: Celina B. Fernandez, MS, role: CONTACT, phone: 5165623646, email: cfernandez14@northwell.edu, geoPoint lat: 40.79788, lon: -73.69957, hasResults: False
protocolSection identificationModule nctId: NCT06378723, orgStudyIdInfo id: 2024/01/24, briefTitle: The Relationship Between Upper Extremity Functionality, Trunk Control and Balance in Children With Cerebral Palsy, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2024-02-01, primaryCompletionDateStruct date: 2024-04-15, completionDateStruct date: 2024-04-16, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-23, sponsorCollaboratorsModule leadSponsor name: Eastern Mediterranean University, class: OTHER, descriptionModule briefSummary: The aim of this study is to examine the relationship between trunk control, upper extremity functionality and balance in children with cerebral palsy and to compare this relationship with healthy sedentary children.This study is carried out through Eastern Mediterranean University Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Pediatric Rehabilitation Unit., conditionsModule conditions: Cerebral Palsy, conditions: Diplegic Cerebral Palsy, conditions: Balance; Distorted, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: OTHER, enrollmentInfo count: 53, type: ACTUAL, armsInterventionsModule interventions name: Balance Tests, outcomesModule primaryOutcomes measure: trunk control, primaryOutcomes measure: upper extremity functionality, primaryOutcomes measure: balance, primaryOutcomes measure: Weight and Height, eligibilityModule sex: ALL, minimumAge: 8 Years, maximumAge: 18 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule locations facility: Eastern Mediterranean University, city: Famagusta, zip: 99628, country: Cyprus, geoPoint lat: 35.12054, lon: 33.93894, locations facility: Yeni Sihirli Eller Özel Eğitim ve Rehabilitasyon Merkezi, city: Adana, state: Çukurova, zip: 01170, country: Turkey, geoPoint lat: 37.00167, lon: 35.32889, hasResults: False
protocolSection identificationModule nctId: NCT06378684, orgStudyIdInfo id: JW22105, briefTitle: To Evaluate the Safety and Pharmacokinetic Interactions in Healthy Volunteers, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-09-10, primaryCompletionDateStruct date: 2023-12-23, completionDateStruct date: 2024-01-13, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-22, sponsorCollaboratorsModule leadSponsor name: JW Pharmaceutical, class: INDUSTRY, descriptionModule briefSummary: The objective is to evaluate the safety and Pharmacokinetic Interactions after adminitration drug(Treatment A or B or A+B) in Healthy Volunteers, conditionsModule conditions: Healthy, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: RANDOMIZED, interventionModel: SEQUENTIAL, primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 48, type: ACTUAL, armsInterventionsModule interventions name: Group 1: JW0104(Period 1), C2207(Period 2), JW0104 + C2207(Period 3), interventions name: Group 2: JW0104 + C2207(Period 1), JW0104(Period 2), C2207(Period 3), interventions name: Group 3: C2207(Period 1), JW0104 + C2207(Period 2), JW0104(Period 3), interventions name: Group 4: JW0104(Period 1), JW0104 + C2207(Period 2), C2207(Period 3), interventions name: Group 5: JW0104 + C2207(Period 1), C2207(Period 2), JW0104(Period 3), interventions name: Group 6: C2207(Period 1), JW0104(Period 2), JW0104 + C2207(Period 3), outcomesModule primaryOutcomes measure: Cmax,ss, primaryOutcomes measure: AUCτ,ss, eligibilityModule sex: ALL, minimumAge: 19 Years, maximumAge: 55 Years, stdAges: ADULT, contactsLocationsModule locations facility: Clinical Trial Center, Severance Hospital, city: Seoul, country: Korea, Republic of, geoPoint lat: 37.566, lon: 126.9784, hasResults: False
protocolSection identificationModule nctId: NCT06378619, orgStudyIdInfo id: CSAPG-50, briefTitle: Tapping Test and the Archimedean Spiral for the Differential Diagnosis of Tremor. Machine Learning Approach, acronym: MATSEP, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2025-06, completionDateStruct date: 2025-06, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-22, sponsorCollaboratorsModule leadSponsor name: Consorci Sanitari de l'Alt Penedès i Garraf, class: OTHER, descriptionModule briefSummary: In clinical practice, it is sometimes difficult to establish whether a patient's tremor is due to Parkinson's disease or essential tremor. The distinction is crucial as the health implications differ significantly between the two conditions. Therefore, the present study aims to develop a diagnostic method based on machine learning techniques to help differentiate whether a patient's tremor is due to one condition or the other. To achieve this, 110 patients with tremor, correctly diagnosed with either Parkinson's disease or essential tremor, will participate. They will undergo two diagnostic tests (tapping test and Archimedean spiral) to capture data that can be processed using machine learning techniques., conditionsModule conditions: Tremor, conditions: Essential Tremor, conditions: Parkinson Disease, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CROSSOVER, timePerspective: PROSPECTIVE, enrollmentInfo count: 110, type: ESTIMATED, armsInterventionsModule interventions name: Tapping Test, interventions name: Archimedes Spiral, outcomesModule primaryOutcomes measure: Sensitivity, primaryOutcomes measure: Specificity, secondaryOutcomes measure: Reliability, eligibilityModule sex: ALL, minimumAge: 45 Years, maximumAge: 79 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Hospital Sant Camil-Consorci Sanitari Alt'Pènedes i Garraf, city: Barcelona, state: Cataluña, zip: 08810, country: Spain, contacts name: José Luis Camacho, MD, role: CONTACT, phone: +34 938960025, email: jlcamacho@csapg.cat, contacts name: Noemí Casaponsa, role: CONTACT, phone: +34 938960025, phoneExt: 43197, email: recerca@csapg.cat, contacts name: José Luis Camacho, MD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 41.38879, lon: 2.15899, hasResults: False
protocolSection identificationModule nctId: NCT06378606, orgStudyIdInfo id: P.T.REC/012/004907, briefTitle: Effect of Technology on Cognitive Function in Elderly, acronym: cogntion, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-07-01, primaryCompletionDateStruct date: 2024-06-01, completionDateStruct date: 2024-06-01, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-22, sponsorCollaboratorsModule leadSponsor name: Nourhan Hesham Ali, class: OTHER, collaborators name: Cairo University, descriptionModule briefSummary: Cognitive technology therapies, including interactive video gaming, computer soft wares and mobile technology, have been used to implement cognitive training and rehabilitation programs. Potential advantages to using technology-based interventions include enhanced accessibility and cost-effectiveness, providing a user experience to be good communicator, immersive and comprehensive., conditionsModule conditions: Cognitive Impairment, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, interventionModelDescription: The aim of study is to find the effects of screen based cognitive therapy on mild dementia in elderly ., primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, maskingDescription: The aim of study is to find the effects of screen based cognitive therapy on mild dementia in elderly ., whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: cognitive therapy, outcomesModule primaryOutcomes measure: Cognitive functions assessment, secondaryOutcomes measure: Quality of life survey, eligibilityModule sex: ALL, minimumAge: 65 Years, maximumAge: 85 Years, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Nour Ali, status: RECRUITING, city: Cairo, state: Giza, zip: 12511, country: Egypt, contacts name: Nour Ali, master, role: CONTACT, phone: 01156860154, email: nourheshame854@gmail.com, geoPoint lat: 30.06263, lon: 31.24967, hasResults: False
protocolSection identificationModule nctId: NCT06378580, orgStudyIdInfo id: LGF22H160084, secondaryIdInfos id: LGF22H160084, type: OTHER_GRANT, domain: Zhejiang Provincial Basic Public Welfare Research Program, briefTitle: The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-07-01, primaryCompletionDateStruct date: 2023-07-01, completionDateStruct date: 2024-04-01, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-22, sponsorCollaboratorsModule leadSponsor name: Luo Cong, class: OTHER, descriptionModule briefSummary: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor with a poor prognosis, despite the emergence of chemotherapies, unmet medical needs and limited treatment options still exist for patients with metastatic PDAC (mPDAC). Surufatinib is a small-molecule tyrosine kinase inhibitor that targets vascular endothelial growth factor (VEGFR) 1, 2, 3, fibroblast growth factor receptor 1 (FGFR1), and colony stimulating factor 1 receptor (CSF-1R), and ex vivo experiments have demonstrated its effect on PC models.A retrospective analysis of patients with PDAC who underwent surufatinib at Zhejiang Cancer Hospital (Hangzhou,China) from July 2022 to July 2023.The database was extracted from the preoperative demographics, blood markers, and surgical pathology information of patients undergoing surufatinib in the investigators' hospital., conditionsModule conditions: Pancreatic Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: RETROSPECTIVE, enrollmentInfo count: 72, type: ACTUAL, armsInterventionsModule interventions name: Surufatinib combine immune checkpoint inhibitor, interventions name: AG/FOLFIRINOX, outcomesModule primaryOutcomes measure: Median progression-free survival, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Zhejiang Province Cancer Hospital, city: Hangzhou, state: Zhejiang, zip: 310000, country: China, geoPoint lat: 30.29365, lon: 120.16142, hasResults: False
protocolSection identificationModule nctId: NCT06378567, orgStudyIdInfo id: HCD J8923, briefTitle: A Study to Assess the Effects of Dietary Supplement Drinks on Sleep, Stress and Mood, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2024-05, completionDateStruct date: 2024-05, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-22, sponsorCollaboratorsModule leadSponsor name: The Water Street Collective, class: INDUSTRY, collaborators name: British American Tobacco (Investments) Limited, collaborators name: HCD Research, descriptionModule briefSummary: A home placement, randomized, double blind, placebo-controlled, study to determine the effect of dietary liquid shot beverage products on self-reported measures of sleep, stress and mood on generally healthy participants with current self-reported mild/moderate sleep difficulties (but not clinical insomnia) and mild/moderate stress., conditionsModule conditions: Sleep, conditions: Mood, conditions: Stress, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Parallel Assignment, primaryPurpose: OTHER, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 180, type: ESTIMATED, armsInterventionsModule interventions name: Dietary supplement liquid shot beverage products, outcomesModule primaryOutcomes measure: Sleep Disturbance, secondaryOutcomes measure: Sleep Impairment, secondaryOutcomes measure: Insomnia Severity, secondaryOutcomes measure: Restorative Sleep, secondaryOutcomes measure: Contentedness/Anxiety, secondaryOutcomes measure: Profile of Mood States (POMS), secondaryOutcomes measure: Daily Sleep diary, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 45 Years, stdAges: ADULT, contactsLocationsModule locations facility: Sago Atlanta - The Palisades Complex, city: Atlanta, state: Georgia, zip: 30328, country: United States, contacts name: Melissa Hall, role: CONTACT, phone: 770-396-8700, email: connect@sago.com, geoPoint lat: 33.749, lon: -84.38798, hasResults: False
protocolSection identificationModule nctId: NCT06378554, orgStudyIdInfo id: IRB00111227, briefTitle: Cereset Research for Performance Improvement in a Hospital Nursing Unit, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2025-05, completionDateStruct date: 2026-05, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-22, sponsorCollaboratorsModule leadSponsor name: Wake Forest University Health Sciences, class: OTHER, collaborators name: Susanne Marcus Collins Foundation, Inc., descriptionModule briefSummary: The purpose of this study is to explore whether an implementation process composed of offering CR to staff in a single hospital nursing unit has any potential impact on unit-level quality measures post-implementation., conditionsModule conditions: Health Personnel, conditions: Stress, conditions: Anxiety, conditions: Job Performance, conditions: Insomnia, conditions: Depression, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: SINGLE_GROUP, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: Cereset Research, outcomesModule primaryOutcomes measure: Percent of ortho trauma unit staff who complete Cereset intervention, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 100 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Wake Forest University Health Sciences, city: Winston-Salem, state: North Carolina, zip: 27157, country: United States, contacts name: Dawn C Higgins, role: CONTACT, phone: 336-716-9447, email: dkellar@wakehealth.edu, geoPoint lat: 36.09986, lon: -80.24422, hasResults: False
protocolSection identificationModule nctId: NCT06378528, orgStudyIdInfo id: 2023-1706, secondaryIdInfos id: Protocol Version Jan 2024, type: OTHER, domain: UW Madison, secondaryIdInfos id: A538900, type: OTHER, domain: UW Madison, briefTitle: Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP), statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-08, primaryCompletionDateStruct date: 2025-08, completionDateStruct date: 2025-08, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-22, sponsorCollaboratorsModule leadSponsor name: University of Wisconsin, Madison, class: OTHER, descriptionModule briefSummary: The objectives of this study are to investigate the feasibility, tolerability, and efficacy of repeated ketamine-assisted psychotherapy sessions in adolescents with severe posttraumatic stress disorder. The study will enroll adolescents with a current diagnosis of posttraumatic stress disorder (PTSD) to complete three intravenous ketamine administrations immediately prior to a psychotherapy session over the span of six weeks. All participants will complete an initial set of preparatory sessions, and each dosing session will be followed by three integration sessions. Finally, participants will complete 7 nights of at-home sleep recordings. The investigators hypothesize that this protocol will be well-tolerated by adolescents and that patients will experience decreases in PTSD symptom severity at follow-up., conditionsModule conditions: Posttraumatic Stress Disorder, designModule studyType: INTERVENTIONAL, phases: EARLY_PHASE1, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: single group, open label, pilot study, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 5, type: ESTIMATED, armsInterventionsModule interventions name: Ketamine, interventions name: SmartSleep EEG recording headband, outcomesModule primaryOutcomes measure: Summary of Adverse Events Attributable to Ketamine Administration, secondaryOutcomes measure: Number of Participants Adhering to the Study Protocol, secondaryOutcomes measure: Number of Visits Completed Throughout the Study Duration, otherOutcomes measure: Changes in PTSD symptom severity as measured by the Clinician Administered PTSD Scale Child/Adolescent Version (CAPS-CA), otherOutcomes measure: Exploratory Measurements: Change waveform recorded with Philips SmartSleep headband, measured in Hz, eligibilityModule sex: ALL, minimumAge: 15 Years, maximumAge: 17 Years, stdAges: CHILD, contactsLocationsModule locations facility: University of Wisconsin, city: Madison, state: Wisconsin, zip: 53705, country: United States, contacts name: Sara Heyn, JD, PhD, role: SUB_INVESTIGATOR, contacts name: Stephanie Jones, PhD, role: SUB_INVESTIGATOR, contacts name: Steven Garlow, MD, PhD, role: SUB_INVESTIGATOR, contacts name: Paul Hutson, PharmD, role: SUB_INVESTIGATOR, geoPoint lat: 43.07305, lon: -89.40123, hasResults: False
protocolSection identificationModule nctId: NCT06378515, orgStudyIdInfo id: Glymphactive, briefTitle: Physical Activity, Sleep and Brain Health Based on the Glymphatic System, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2025-04, completionDateStruct date: 2025-12, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-22, sponsorCollaboratorsModule leadSponsor name: University of Valencia, class: OTHER, collaborators name: University of Oulu, descriptionModule briefSummary: This study is aiming to analyze the impact of physical activity on neurohydrodynamics and glymphatic activity on young adults. This study is designed as a multicenter descriptive observational study with information collection at two different times: before performing a short exercise routine and during its performance using a wearable wireless device Glymphometer., conditionsModule conditions: Brain Diseases, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 77, type: ESTIMATED, armsInterventionsModule interventions name: Physical activity, postural changes and cognitive tasks, outcomesModule primaryOutcomes measure: Brain health, secondaryOutcomes measure: Physical activity (habitual), secondaryOutcomes measure: Sleep duration, secondaryOutcomes measure: Sleep Quality, secondaryOutcomes measure: Chronotype, secondaryOutcomes measure: Self-reported health status, secondaryOutcomes measure: Other variables, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06378502, orgStudyIdInfo id: antibiotic-resistence, briefTitle: The Effect of Different Antibiotic Protocols on Peri-implant Tissue Health, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-03, primaryCompletionDateStruct date: 2025-12-30, completionDateStruct date: 2026-06-30, studyFirstPostDateStruct date: 2024-04-22, lastUpdatePostDateStruct date: 2024-04-22, sponsorCollaboratorsModule leadSponsor name: Universita degli Studi di Genova, class: OTHER, descriptionModule briefSummary: The aim of the present project (non-inferiority trial) is to evaluate the effect of different antibiotic strategies (long-span vs. short-span) for implant surgery on peri-implant tissue health, oral microbiome (included resistome) and salivary MiRNomics in healthy patients., conditionsModule conditions: Antibiotic, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Amoxicillin Short, interventions name: Amoxicillin Long, outcomesModule primaryOutcomes measure: Mean peri-implant bone loss, secondaryOutcomes measure: Incidence of biological and technical complications at the implant site, secondaryOutcomes measure: implant survival rate, secondaryOutcomes measure: Antibiotic sensitivity, secondaryOutcomes measure: Peri-implant myco-, microbiome and resistome, secondaryOutcomes measure: Salivary miRNomics, secondaryOutcomes measure: Adverse reactions, secondaryOutcomes measure: Development of a 3D bone model, secondaryOutcomes measure: Plaque index (PI), secondaryOutcomes measure: Bleeding on probing (BOP), secondaryOutcomes measure: Peri-implant pocket probing depth (PPD), eligibilityModule sex: ALL, minimumAge: 35 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False